Mechanistically, MBD2 selectively binds to the methylated CpG DNA in the Stat1 promoter, by which it represses STAT1-IFN-γ signaling to maintain the homeostasis of the Th1 program, and similar results were obtained in T1D patients as well. This evidence concerns the gene MBD2 and type 1 diabetes mellitus.